00

Hubei Guangji Pharmaceutical Co Ltd

000952 · SHE · Healthcare / Drug Manufacturers - General

5.68CNY-0.10 (-1.73%)

Price History

Full chart

Market Stats

Previous Close5.78
Open5.83
Day Range5.65 – 5.83
52-Week Range5.00 – 10.42
Volume3.83M
Market Cap2.26B
P/E (TTM)0.00
Forward P/E107.53
EPS-1.11
Dividend Yield0.00%
Beta0.27
50-Day Avg6.22
200-Day Avg6.90

About

Hubei Guangji Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical raw materials, pharmaceutical preparations, and feed additives in China and internationally. The company also exports its products. Hubei Guangji Pharmaceutical Co., Ltd. was founded in 1969 and is based in Wuxue, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - General
  • CEOMr. Cheng Gong
  • Employees1.16K
  • HeadquartersNo. 100, Meiwu Road, Wuxue, China, 435400, China
  • Websitehttps://www.guangjipharm.com

Leadership

  • Mr. Cheng GongGM & Director · b. 1987
  • Mr. Yi XiongChief Financial Officer · b. 1976
  • Mr. Shao Zhi GuoDeputy GM & Director · b. 1969
  • Mr. Zhi FangDeputy GM & Employee Director · b. 1982
  • Mr. Yanhua ZhaoDeputy General Manager · b. 1987
  • Xiaojuan LiuAccounting Supervisor

Financials

Income Statement

Currency: CNY1996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue114.88M141.24M161.31M176.57M134.15M186.10M202.16M204.10M276.63M345.83M388.70M794.90M571.78M448.20M483.32M453.32M394.16M487.08M485.86M560.36M714.72M801.56M843.83M731.34M688.17M785.57M797.64M737.82M638.80M623.97M
Growth (%)-+22.94%+14.21%+9.46%-24.03%+38.73%+8.63%+0.96%+35.54%+25.02%+12.39%+104.51%-28.07%-21.61%+7.84%-6.21%-13.05%+23.58%-0.25%+15.33%+27.55%+12.15%+5.27%-13.33%-5.90%+14.15%+1.54%-7.50%-13.42%-2.32%
Cost of Revenue68.57M71.08M89.32M98.19M68.75M105.47M127.30M130.81M209.09M260.88M271.51M337.91M341.18M353.85M388.60M359.43M392.97M431.92M470.11M383.72M342.89M397.70M364.94M396.06M413.75M487.42M510.22M549.89M524.77M458.17M
Gross Profit46.32M70.16M71.99M78.38M65.39M80.63M74.86M73.28M67.53M84.96M117.18M457.00M230.60M94.35M94.71M93.89M1.18M55.16M15.75M176.64M371.83M403.86M478.89M335.28M274.42M298.15M287.42M187.93M114.03M165.80M
Gross Margin40.32%49.67%44.63%44.39%48.75%43.33%37.03%35.91%24.41%24.57%30.15%57.49%40.33%21.05%19.60%20.71%0.30%11.32%3.24%31.52%52.02%50.38%56.75%45.85%39.88%37.95%36.03%25.47%17.85%26.57%
Operating Expense26.82M34.51M41.23M44.19M28.38M48.33M47.54M55.39M54.34M66.75M83.37M175.25M116.31M53.51M89.40M96.74M94.59M113.22M242.21M154.72M214.76M268.56M267.75M236.41M177.58M179.95M226.64M328.99M431.93M277.88M
Operating Income19.50M35.64M30.76M34.19M37.01M32.30M27.32M17.90M13.19M18.21M33.81M281.74M114.29M40.84M5.31M-2.84M-93.41M-58.06M-226.45M21.92M157.07M135.29M211.14M98.87M96.84M118.20M60.78M-141.05M-317.90M-112.08M
Operating Margin16.97%25.24%19.07%19.36%27.59%17.36%13.52%8.77%4.77%5.26%8.70%35.44%19.99%9.11%1.10%-0.63%-23.70%-11.92%-46.61%3.91%21.98%16.88%25.02%13.52%14.07%15.05%7.62%-19.12%-49.76%-17.96%
EBITDA27.38M46.25M52.23M60.32M54.72M61.58M58.00M52.31M48.37M60.27M69.98M324.33M156.76M85.42M80.26M83.47M-14.88M89.26M-126.10M108.67M265.01M237.76M321.66M216.45M211.49M232.12M179.08M27.23M-93.74M-231.66M
EBITDA Margin23.83%32.74%32.38%34.16%40.79%33.09%28.69%25.63%17.48%17.43%18.00%40.80%27.42%19.06%16.61%18.41%-3.78%18.33%-25.95%19.39%37.08%29.66%38.12%29.60%30.73%29.55%22.45%3.69%-14.67%-37.13%
Net Income17.41M32.03M25.75M31.42M30.62M24.59M19.87M7.70M8.21M8.56M15.66M183.80M89.10M43.00M13.98M4.85M-95.56M2.42M-218.73M20.92M141.84M105.21M171.73M86.94M74.65M110.11M50.33M-140.25M-295.29M-404.49M
Net Income Margin15.16%22.68%15.96%17.80%22.82%13.21%9.83%3.77%2.97%2.48%4.03%23.12%15.58%9.59%2.89%1.07%-24.25%0.50%-45.02%3.73%19.85%13.13%20.35%11.89%10.85%14.02%6.31%-19.01%-46.23%-64.83%
R&D--------------5.79M7.44M11.84M74.69M25.31M11.23M30.28M47.50M64.68M53.77M38.77M52.06M68.98M74.75M56.82M41.91M
R&D as % of Total Revenue--------------1.20%1.64%3.00%15.33%5.21%2.00%4.24%5.93%7.67%7.35%5.63%6.63%8.65%10.13%8.89%6.72%
Interest Expense8.26M11.30M10.92M12.11M5.76M9.19M11.45M11.67M11.77M15.93M13.49M10.93M4.98M4.56M12.82M21.07M24.88M28.78M28.76M35.80M36.27M33.67M31.77M35.27M32.90M16.91M21.55M49.15M62.36M51.16M
Interest Expense % of Total Revenue7.19%8.00%6.77%6.86%4.29%4.94%5.66%5.72%4.25%4.61%3.47%1.37%0.87%1.02%2.65%4.65%6.31%5.91%5.92%6.39%5.07%4.20%3.77%4.82%4.78%2.15%2.70%6.66%9.76%8.20%

Balance Sheet

Currency: CNY1996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets244.89M333.05M378.76M648.78M676.22M761.83M819.91M866.94M911.95M882.44M785.02M998.76M1.21B1.30B1.38B1.51B1.56B1.55B1.58B1.62B1.63B1.64B1.69B1.77B1.98B2.05B2.47B3.03B2.79B2.31B
Total Liabilities110.72M166.84M186.80M199.49M194.67M274.96M313.05M352.38M388.76M350.68M307.34M325.76M395.78M486.93M545.06M643.07M795.93M816.78M1.08B1.11B974.70M876.65M812.33M802.21M613.75M598.09M977.25M1.64B1.72B1.69B
Total Equity134.18M166.21M191.95M449.30M481.54M486.87M506.86M514.56M522.77M531.34M477.26M667.19M748.30M792.49M806.47M816.04M718.95M716.90M498.17M512.19M654.03M759.24M873.28M960.38M1.37B1.46B1.50B1.36B1.06B653.77M
Cash2.78M2.92M6.87M83.24M92.10M95.48M135.76M58.06M35.66M22.11M62.11M172.21M220.12M188.81M211.75M152.30M125.01M111.04M194.78M161.93M116.74M140.83M173.55M183.65M350.31M293.33M431.35M415.24M307.18M278.49M
Total Debt82.92M99.97M132.53M127.42M114.43M189.80M225.17M251.17M291.37M264.00M212.50M78.00M81.00M277.68M328.98M367.54M376.11M281.74M505.99M515.74M506.92M531.38M551.92M596.50M303.84M372.83M605.39M710.60M739.35M-
Net Debt80.14M97.05M125.66M44.18M22.33M94.32M89.41M193.11M255.71M241.89M150.39M-94.21M-139.12M88.87M117.22M215.24M251.10M170.70M311.21M353.81M390.19M390.54M378.37M412.85M-46.47M79.49M174.03M295.36M432.17M452.79M

Cash Flow

Currency: CNY1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-15.29M68.57M48.57M-22.40M76.20M-15.40M-3.32M54.14M125.95M331.98M220.70M-24.35M77.18M81.88M108.02M95.16M-74.69M-33.35M167.07M178.83M231.44M144.20M119.38M75.91M45.08M-148.96M655.36K60.43M
Investing Cash Flow-2.96M-218.65M-38.21M-19.82M-51.92M-75.84M-47.51M-24.65M-20.97M-77.76M-168.71M-193.34M-95.71M-171.25M-118.13M-4.77M-79.01M-119.56M-109.08M-79.67M-76.22M-119.49M-112.82M-114.10M-121.74M-565.78M-152.78M-
Financing Cash Flow22.20M226.45M-1.50M45.61M16.00M13.52M28.43M-43.10M-64.99M-144.88M-4.07M186.38M41.47M29.92M-17.18M-120.76M241.24M114.92M-95.87M-67.80M-122.42M-16.80M103.14M-46.77M300.94M701.09M42.84M-
Capital Expenditure2.96M135.58M25.11M46.84M50.52M65.74M47.58M25.84M18.73M48.94M219.76M149.93M115.57M200.96M117.46M50.04M94.63M109.94M112.94M80.91M76.53M119.76M97.89M96.61M203.71M566.13M154.93M35.64M
Free Cash Flow-18.25M-67.01M23.46M-69.25M25.68M-81.14M-50.90M28.30M107.23M283.03M937.45K-174.28M-38.39M-119.08M-9.44M45.12M-169.32M-143.28M54.13M97.92M154.91M24.44M21.49M-20.70M-158.63M-715.10M-154.28M24.79M
Dividends Paid10.89M12.50M13.09M9.64M19.37M12.48M11.77M15.73M13.49M10.38M26.75M6.19M12.82M21.07M25.76M26.38M21.25M36.07M35.52M31.83M50.92M29.34M77.40M20.64M21.16M31.56M50.46M50.95M
FCF to OCF119.35%-97.72%48.31%309.12%33.70%526.93%1534.43%52.27%85.13%85.26%0.42%715.79%-49.74%-145.44%-8.74%47.42%226.69%429.69%32.40%54.76%66.93%16.95%18.00%-27.27%-351.88%480.05%-23540.79%41.02%
Dividend Paid to FCF-59.69%-18.65%55.78%-13.92%75.45%-15.38%-23.11%55.58%12.58%3.67%2853.17%-3.55%-33.38%-17.69%-272.88%58.47%-12.55%-25.17%65.62%32.51%32.87%120.04%360.18%-99.71%-13.34%-4.41%-32.71%205.53%

Earnings

Report DateOct 28, 2014Dec 31, 2014Apr 29, 2015Aug 18, 2015Oct 29, 2015Feb 29, 2016Apr 27, 2016Aug 22, 2016Oct 18, 2016Feb 28, 2017Apr 27, 2017Aug 21, 2017Oct 24, 2017Mar 15, 2018Apr 26, 2018Aug 27, 2018Oct 29, 2018Mar 15, 2019Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Apr 30, 2020Aug 21, 2020Oct 30, 2020Mar 24, 2021Apr 27, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023May 29, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024May 29, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate------------------------------------------------
EPS Actual-0.13-0.52-0.02-0.050.010.130.080.110.220.060.080.090.100.080.280.110.050.130.100.110.14-0.06-0.050.090.080.080.040.130.040.100.020.05-0.010.08-0.130.05-0.12-0.21-0.15-0.16-0.15-0.40-0.11-0.11-0.06-0.89-0.09-0.08
Surprise------------------------------------------------
TimingAfter-hours-After-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-market--------------------After-hours---After-hours-----

Key Statistics & Ratios

Market Cap2.26B
Enterprise Value3.31B
Trailing P/E0.00
Forward P/E107.53
PEG Ratio0.00
Price / Sales3.47
Price / Book3.78
EPS-1.11
Book Value1.74
Revenue (TTM)651.57M
Gross Profit (TTM)126.69M
EBITDA7.48M
Profit Margin-59.38%
Operating Margin-13.87%
Return on Equity-53.76%
Return on Assets-3.39%
Shares Outstanding344.00M
Shares Float237.02M
Beta0.27
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20221×
0.06May 27, 2022
20211×
0.06May 28, 2021
20201×
0.06May 29, 2020
20181×
0.09Jun 15, 2018
20081×
0.08May 23, 2008
20021×
0.02Jun 26, 2002
20001×
0.02May 18, 2000

Stock Splits

  • May 29, 20201.2:1
  • Jul 24, 200620.5626:10